PETERSON TYCHO 4
4 · Adaptive Biotechnologies Corp · Filed Jun 20, 2023
Insider Transaction Report
Form 4
PETERSON TYCHO
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-06-15$7.30/sh+14,328$104,594→ 413,547 total - Sale
Common Stock
2023-06-15$8.53/sh−55,672$474,882→ 399,219 total - Sale
Common Stock
2023-06-15$8.53/sh−14,328$122,218→ 399,219 total - Exercise/Conversion
Stock Option (right to buy)
2023-06-15−14,328→ 582,829 totalExercise: $7.30Exp: 2032-06-01→ Common Stock (14,328 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to $8.72, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- [F3]The options vested with respect to 1/4 of such shares on June 1, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.